CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 24 filers reported holding CARDIOME PHARMA CORP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $118,000 | +47.5% | 51,200 | -0.4% | 0.00% | – |
| Q4 2017 | $80,000 | -27.3% | 51,400 | 0.0% | 0.00% | – |
| Q3 2017 | $110,000 | -52.6% | 51,400 | 0.0% | 0.00% | – |
| Q2 2017 | $232,000 | +45.0% | 51,400 | -3.0% | 0.00% | – |
| Q1 2017 | $160,000 | +9.6% | 53,000 | 0.0% | 0.00% | – |
| Q4 2016 | $146,000 | -12.0% | 53,000 | 0.0% | 0.00% | – |
| Q3 2016 | $166,000 | -8.8% | 53,000 | +49.0% | 0.00% | – |
| Q2 2016 | $182,000 | +24.7% | 35,580 | 0.0% | 0.00% | – |
| Q1 2016 | $146,000 | -48.2% | 35,580 | +2.1% | 0.00% | – |
| Q4 2015 | $282,000 | +13.7% | 34,840 | +18.7% | 0.00% | – |
| Q3 2015 | $248,000 | 0.0% | 29,360 | +11.1% | 0.00% | – |
| Q2 2015 | $248,000 | +40.9% | 26,420 | +38.6% | 0.00% | – |
| Q1 2015 | $176,000 | +57.1% | 19,060 | +57.3% | 0.00% | – |
| Q4 2014 | $112,000 | +166.7% | 12,120 | +155.7% | 0.00% | – |
| Q3 2014 | $42,000 | – | 4,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |